|
US5643578A
(en)
|
1992-03-23 |
1997-07-01 |
University Of Massachusetts Medical Center |
Immunization by inoculation of DNA transcription unit
|
|
US5620896A
(en)
*
|
1992-03-23 |
1997-04-15 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
|
US6165993A
(en)
*
|
1992-03-23 |
2000-12-26 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
|
US6127116A
(en)
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
|
DE69608122T3
(de)
*
|
1995-11-09 |
2011-06-16 |
Microbiological Research Authority Camr, Salisbury |
Mikroverkapselte dna zur impfung und gentherapie
|
|
GB9709900D0
(en)
*
|
1997-05-15 |
1997-07-09 |
Microbiological Res Authority |
Microencapsulated DNA for vaccination and gene therapy
|
|
US5741492A
(en)
*
|
1996-01-23 |
1998-04-21 |
St. Jude Children's Research Hospital |
Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
|
|
US6723558B1
(en)
|
1996-01-23 |
2004-04-20 |
St. Jude Children's Research Hospital |
Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
|
|
AU2118997A
(en)
*
|
1996-02-05 |
1997-08-22 |
Johns Hopkins University, The |
Measles immunization by dna transcription unit inoculation
|
|
PL328730A1
(en)
*
|
1996-02-22 |
1999-02-15 |
Merck & Co Inc |
Synthetic hiv genes
|
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
CA2258568A1
(en)
*
|
1996-06-21 |
1997-12-24 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
AU3514197A
(en)
|
1996-07-03 |
1998-01-21 |
Genetics Institute Inc. |
Protease fmh-1, an ice/ced-like protease
|
|
FR2751224B1
(fr)
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
|
|
FR2751223B1
(fr)
*
|
1996-07-19 |
1998-12-04 |
Rhone Merieux |
Formule de vaccin polynucleotidique felin
|
|
FR2751226B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies du cheval
|
|
FR2751225B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique aviaire
|
|
FR2751227B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
|
US7294338B2
(en)
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
FR2751228B1
(fr)
*
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Vaccin polynucleotidique bovin pour voie intradermique
|
|
FR2751229B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
|
|
US5783567A
(en)
*
|
1997-01-22 |
1998-07-21 |
Pangaea Pharmaceuticals, Inc. |
Microparticles for delivery of nucleic acid
|
|
US6696291B2
(en)
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
|
CN1044092C
(zh)
|
1997-02-26 |
1999-07-14 |
上海医科大学 |
抗原－抗体－重组dna复合型疫苗
|
|
US7049428B1
(en)
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
|
UA78180C2
(uk)
|
1997-10-03 |
2007-03-15 |
Меріаль |
Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
|
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
|
US6548302B1
(en)
|
1998-06-18 |
2003-04-15 |
Johns Hopkins University School Of Medicine |
Polymers for delivery of nucleic acids
|
|
US6916490B1
(en)
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
|
GB9818627D0
(en)
|
1998-08-26 |
1998-10-21 |
Glaxo Group Ltd |
Improvements in dva vaccination
|
|
US6881723B1
(en)
|
1998-11-05 |
2005-04-19 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
AU3593200A
(en)
|
1999-02-09 |
2000-08-29 |
Powderject Vaccines, Inc. |
(mycobacterium tuberculosis), immunization
|
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
|
US7078388B2
(en)
|
2000-01-21 |
2006-07-18 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
US6852705B2
(en)
|
2000-01-21 |
2005-02-08 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
AUPS054702A0
(en)
|
2002-02-14 |
2002-03-07 |
Immunaid Pty Ltd |
Cancer therapy
|
|
US6982156B2
(en)
|
2002-03-27 |
2006-01-03 |
Trustees Of The University Of Pennsylvania |
Compositions and methods modulating variola and vaccinia virus
|
|
US6783759B2
(en)
|
2002-03-27 |
2004-08-31 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for modulating variola virus
|
|
PT1685251E
(pt)
|
2003-10-10 |
2014-04-15 |
Powderject Vaccines Inc |
Construções de ácido nucleico
|
|
PL1692516T3
(pl)
|
2003-10-24 |
2011-05-31 |
Immunaid Pty Ltd |
Sposób terapii
|
|
AU2005249450A1
(en)
|
2004-05-27 |
2005-12-15 |
Centocor, Inc. |
Cynomolgus prostate specific antigen
|
|
US20060121031A1
(en)
|
2004-12-07 |
2006-06-08 |
Mckenzie Brent S |
Relay vaccine
|
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
|
PL2164862T3
(pl)
|
2007-06-08 |
2015-12-31 |
Australian Poultry Crc Pty Ltd |
Toksyna netb z clostridium
|
|
US8426565B2
(en)
|
2007-08-30 |
2013-04-23 |
Walter And Eliza Hall Institute Of Medical Research |
Dendritic cell marker and uses thereof
|
|
PT2435825E
(pt)
|
2009-05-27 |
2015-11-02 |
Biotempus Ltd |
Métodos para o tratamento de doenças
|
|
AR078253A1
(es)
|
2009-09-02 |
2011-10-26 |
Boehringer Ingelheim Vetmed |
Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
|
|
BR112012028893A2
(pt)
|
2010-05-10 |
2017-12-12 |
Ascend Biopharmaceuticals Pty Ltd |
composições imunoestimuladoras e de vacina
|
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
|
WO2013033092A2
(en)
|
2011-09-03 |
2013-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Streptococcus suis pilus antigens
|
|
AU2012327878A1
(en)
|
2011-10-28 |
2014-05-29 |
Patrys Limited |
PAT-LM1 epitopes and methods for using same
|
|
EP2958586B1
(en)
|
2013-02-21 |
2018-09-05 |
Boehringer Ingelheim Vetmedica GmbH |
H5 proteins of h5n1 influenza virus for use as a medicament
|
|
JP6395855B2
(ja)
|
2014-04-03 |
2018-09-26 |
ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド |
ブタ流行性下痢ウイルスワクチン
|
|
WO2016000022A1
(en)
|
2014-06-30 |
2016-01-07 |
Murdoch Childrens Research Institute |
Helicobacter therapeutic
|
|
TWI799365B
(zh)
|
2015-08-31 |
2023-04-21 |
德商百靈佳殷格翰維美迪加股份有限公司 |
用於先天性痙攣症之瘟疫病毒疫苗
|
|
US20170072042A1
(en)
|
2015-09-16 |
2017-03-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Salmonella choleraesuis-salmonella typhimurium vaccines
|
|
MX2019003161A
(es)
|
2016-09-20 |
2019-05-27 |
Boehringer Ingelheim Vetmedica Gmbh |
Nuevo sitio de insercion orf70 de ehv.
|
|
NZ751966A
(en)
|
2016-09-20 |
2023-03-31 |
Boehringer Ingelheim Vetmedica Gmbh |
New promoters
|
|
WO2018057441A1
(en)
|
2016-09-20 |
2018-03-29 |
Boehringer Ingelheim Vetmedica Gmbh |
Canine adenovirus vectors
|
|
CA3036310A1
(en)
|
2016-09-20 |
2018-03-29 |
Boehringer Ingelheim Vetmedica Gmbh |
New swine influenza vaccine
|
|
PT3534939T
(pt)
|
2016-11-03 |
2023-04-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Vacina contra parvovírus porcino e vírus da síndrome reprodutiva e respiratória porcina e métodos da sua produção
|
|
US10485866B2
(en)
|
2016-11-03 |
2019-11-26 |
Boehringer Ingelheim Vetmedica Gmbh |
Vaccine against porcine parvovirus
|
|
EA201991762A1
(ru)
|
2017-01-30 |
2020-01-23 |
Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. |
Вакцины против коронавируса свиней
|
|
US11179457B2
(en)
|
2017-07-12 |
2021-11-23 |
Boehringer Ingelheim Animal Health USA Inc. |
Senecavirus a immunogenic compositions and methods thereof
|
|
MX2020003071A
(es)
|
2017-09-23 |
2020-07-28 |
Boehringer Ingelheim Vetmedica Gmbh |
Sistema de expresion de paramyxoviridae.
|
|
WO2019092027A1
(en)
|
2017-11-09 |
2019-05-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Sapelovirus immunogenic compositions and uses thereof
|
|
WO2019162294A1
(en)
|
2018-02-23 |
2019-08-29 |
Boehringer Ingelheim Vetmedica Gmbh |
Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
|
|
EA202092165A1
(ru)
|
2018-03-19 |
2021-02-25 |
Бёрингер Ингельхайм Ветмедика Гмбх |
Новый ehv сайт инсерции ul43
|
|
US11384365B2
(en)
|
2018-03-19 |
2022-07-12 |
Boehringer Ingelheim Vetmedica Gmbh |
EHV with inactivated UL18 and/or UL8
|
|
CN119488586A
(zh)
|
2018-03-26 |
2025-02-21 |
勃林格殷格翰动物保健美国有限公司 |
制备免疫原性组合物的方法
|
|
KR102879825B1
(ko)
|
2018-09-20 |
2025-11-03 |
베링거잉겔하임베트메디카게엠베하 |
변형된 pedv 스파이크 단백질
|
|
US10905758B2
(en)
|
2018-09-20 |
2021-02-02 |
Boehringer Ingelheim Vetmedica Gmbh |
Intranasal vector vaccine against porcine epidemic diarrhea
|
|
CN115768784A
(zh)
|
2020-02-06 |
2023-03-07 |
勃林格殷格翰动物保健有限公司 |
用于检测抗弹状病毒抗体的多肽
|
|
CA3195910A1
(en)
|
2020-10-05 |
2022-04-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Fusion protein useful for vaccination against rotavirus
|
|
US20220160864A1
(en)
|
2020-10-05 |
2022-05-26 |
Boehringer Ingelheim Animal Health USA Inc. |
Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof
|
|
WO2023194913A1
(en)
|
2022-04-05 |
2023-10-12 |
Boehringer Ingelheim Vetmedica Gmbh |
Immunogenic composition useful for vaccination against rotavirus
|